4.6 Review

Hotspots of Somatic Genetic Variation in Pituitary Neuroendocrine Tumors

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

UniProt: the Universal Protein Knowledgebase in 2023

Alex Bateman et al.

Summary: The UniProt Knowledgebase aims to provide comprehensive, high-quality, and freely accessible protein sequences annotated with functional information. The database has expanded its data processing pipeline and website to accommodate the increasing information content, with over 227 million sequences and plans to include a reference proteome for each taxonomic group. Detailed annotations are extracted from the literature to update or create reviewed entries, while unreviewed entries are supplemented with annotations from automated systems. The new website, https://www.uniprot.org/, offers enhanced user experience and easy access to data, including AlphaFold structures and improved protein subcellular localization visualizations.

NUCLEIC ACIDS RESEARCH (2023)

Review Oncology

The World Health Organization classifications of pituitary neuroendocrine tumours: a clinico-pathological appraisal

Chiara Villa et al.

Summary: The classification of pituitary tumours has been revised in the recent editions of the World Health Organization classifications. The new classification aligns adenohypophyseal tumours with neuroendocrine neoplasia and introduces the term pituitary neuroendocrine tumour (PitNET) instead of adenoma. Pituitary carcinoma is replaced by metastatic PitNET. Immunohistochemistry-based histological typing is considered important for accurate classification.

ENDOCRINE-RELATED CANCER (2023)

Review Oncology

New Approaches to Targeted Therapy in Melanoma

Manuel Felipe Fernandez et al.

Summary: Immune checkpoint inhibitors and BRAF/MEK inhibitors are the main treatments for melanoma, but resistance to these therapies emphasizes the need for new treatment options. Monoclonal antibodies and small molecules allow targeted therapy by focusing on specific mediators of cancer. Melanoma has several driver mutations, and targeting them could lead to novel therapies.

CANCERS (2023)

Article Endocrinology & Metabolism

Prevalence and clinical correlations of SF3B1 variants in lactotroph tumours

Julia Simon et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2023)

Review Biochemistry & Molecular Biology

The Role of Activation of PI3K/AKT/mTOR and RAF/MEK/ERK Pathways in Aggressive Pituitary Adenomas-New Potential Therapeutic Approach-A Systematic Review

Aleksandra Derwich et al.

Summary: Pituitary tumors, while mostly benign, can be aggressive and invasive, resistant to treatment, and prone to recurrence. The underlying mechanisms behind their behavior and metastasis are not fully understood. The RAF/MEK/ERK and PI3K/AKT/mTOR pathways are crucial in cell growth and tumorigenesis. This review aims to explore the activation of these pathways in pituitary tumors and their potential as new therapeutic approaches. Thorough research is needed to ascertain their exact functions and mechanisms in the pathogenesis of pituitary adenomas.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Medicine, General & Internal

BRAF-MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas

Priscilla K. Brastianos et al.

Summary: This study investigated the safety and efficacy of the BRAF-MEK inhibitor combination vemurafenib-cobimetinib in patients with papillary craniopharyngiomas. Results showed that 15 out of 16 patients had a durable objective partial response or better to the therapy. The median reduction in tumor volume was 91%, and the progression-free survival rates at 12 and 24 months were 87% and 58% respectively.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

Article Medicine, Research & Experimental

Clinical Spectrum of USP8 Pathogenic Variants in Cushing's Disease

Rosa G. Rebollar-Vega et al.

ARCHIVES OF MEDICAL RESEARCH (2023)

Review Endocrinology & Metabolism

Review article: new treatments for advanced differentiated thyroid cancers and potential mechanisms of drug resistance

Sarah Hamidi et al.

Summary: The treatment of advanced, radioiodine refractory, differentiated thyroid cancers (RR-DTCs) has seen significant advancements in the past decade, leading to a paradigm shift in patient management and prognosis. Improved understanding of tumor molecular drivers and access to next generation sequencing have resulted in the development and FDA-approval of targeted therapies for RR-DTCs, including multikinase inhibitors and fusion-specific kinase inhibitors. However, current treatments are not curative, and research efforts are focused on identifying and overcoming resistance mechanisms to tyrosine kinase inhibitors.

FRONTIERS IN ENDOCRINOLOGY (2023)

Article Clinical Neurology

Dabrafenib monotherapy for a recurrent BRAFV600E-mutated TTF-1-positive posterior pituitary tumor

Flavie Grenier-Chartrand et al.

Summary: Posterior pituitary tumors (PPT) expressing thyroid transcription factor-1 (TTF-1) are rare, but the recent discovery of BRAF mutations in these tumors offers a potential alternative treatment using BRAF inhibitors.

ACTA NEUROCHIRURGICA (2022)

Article Clinical Neurology

Expanding the clinical and molecular spectrum of pituitary blastoma

Anthony Pak-Yin Liu et al.

ACTA NEUROPATHOLOGICA (2022)

Review Cell Biology

The RASopathies: from pathogenetics to therapeutics

Katie E. Hebron et al.

Summary: The RASopathies are a group of disorders caused by germline mutations in genes encoding components of the RAS/MAPK pathway. This review discusses the pathogenesis of RASopathy-associated genetic variants and the knowledge gained about RAS/MAPK signaling through studying RASopathies. It also explores cell and animal models of RASopathies, emerging RASopathy genes, and the potential use of targeted agents for treating RASopathies. Lastly, it discusses how drugs targeting RAS/MAPK-driven malignancies could be leveraged for patients with RASopathies.

DISEASE MODELS & MECHANISMS (2022)

Article Oncology

Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia

Alessandro Broccoli et al.

Summary: The study examined the measurement of BRAF(V600E) burden in HCL patients at different disease stages, showing that some patients may achieve molecular remission after treatment.

HEMATOLOGICAL ONCOLOGY (2022)

Article Endocrinology & Metabolism

Responsiveness to DDAVP in Cushing's disease is associated with USP8 mutations through enhancing AVPR1B promoter activity

Hiroki Shichi et al.

Summary: This study aimed to clarify the characteristics and underlying mechanisms of Cushing's disease (CD) patients who respond to the desmopressin (DDAVP) test. The study found that CD patients with USP8 mutations had greater responsiveness to DDAVP, and the DDAVP test could predict the presence of USP8 mutations.

PITUITARY (2022)

Article Oncology

P720R USP8 Mutation Is Associated with a Better Responsiveness to Pasireotide in ACTH-Secreting PitNETs

Donatella Treppiedi et al.

Summary: This study investigated the impact of USP8 mutations on the responsiveness of ACTH-secreting pituitary tumors to pasireotide treatment. The study found that USP8 mutations, except for the mutation P720R, reduced the response of tumor cells to pasireotide. These data demonstrate opposite effects of different USP8 mutations on the effectiveness of pasireotide in ACTH-secreting pituitary tumors.

CANCERS (2022)

Article

A review of DICER1: structure, function and contribution to disease

Karleen M. Meiklejohn et al.

Diagnostic Histopathology (2022)

Article Oncology

The Expression of Cell Cycle-Related Genes in USP8-Mutated Corticotroph Neuroendocrine Pituitary Tumors and Their Possible Role in Cell Cycle-Targeting Treatment

Beata Joanna Mossakowska et al.

Summary: This study investigates the role of deubiquitinase gene mutations in predicting the response to cell cycle inhibitors in patients with corticotroph pituitary tumors. The findings suggest that USP8 and USP48 mutations have significant effects on cell cycle-related genes and may influence the response to small molecule inhibitors. However, in vitro experiments show that overexpression or modulation of p27 expression does not affect treatment response.

CANCERS (2022)

Article Biology

Proteogenomic landscape and clinical characterization of GH-producing pituitary adenomas/somatotroph pituitary neuroendocrine tumors

Azusa Yamato et al.

Summary: This study integrates the genetic alterations, protein expressions, and clinical characteristics of growth hormone-producing pituitary adenomas/somatotroph pituitary neuroendocrine tumors to identify molecules associated with acromegaly characteristics. The results reveal a biological connection between GNAS mutations and the clinical and biochemical characteristics of acromegaly, providing potential targets for medical treatment efficacy.

COMMUNICATIONS BIOLOGY (2022)

Article Genetics & Heredity

Genetic drivers of Cushing 's disease: Frequency and associated phenotypes

Laura C. Hernandez-Ramirez et al.

Summary: This study aimed to determine the frequency and associated phenotypes of genetic drivers of Cushing's disease (CD). The study found that about 12.2% of patients had variants of interest at the germline level, 7.8% had variants at the somatic level, and 0.4% had coexisting germline and somatic variants.

GENETICS IN MEDICINE (2022)

Correction Pathology

PRAME protein expression in DICER1-related tumours (vol 8, pg 294, 2022)

Paul S. Thorner et al.

JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2022)

Review Oncology

Novel targeted treatments in hairy cell leukemia and other hairy cell-like disorders

Elsa Maitre et al.

Summary: This article discusses different diseases in the category of mature B-cell neoplasms, such as HCL, SMZL, SDRPL, and SBLPN, and mentions the mutations and signaling pathways associated with these diseases, as well as introduces some new targeted therapies.

FRONTIERS IN ONCOLOGY (2022)

Article Cell Biology

Integrated proteogenomic characterization across major histological types of pituitary neuroendocrine tumors

Fan Zhang et al.

Summary: Pituitary neuroendocrine tumor (PitNET) is a common intracranial tumor, and further studies are needed to explore the causative molecular mechanisms and potential therapeutic targets. Through integrative genomics analysis on 200 PitNET patients, potential therapeutic targets were identified, providing possibilities for improving current treatment strategies.

CELL RESEARCH (2022)

Article Endocrinology & Metabolism

USP8, USP48, and BRAF mutations differ in their genotype-phenotype correlation in Asian Indian patients with Cushing's disease

Ananth P. Abraham et al.

Summary: The study revealed a 37% prevalence of USP8 mutations in Cushing's disease patients from the Indian subcontinent, with a 13.8% prevalence of USP48 mutations in USP8 wild-type adenomas and no BRAF mutations found. It was found that USP8 mutations were significantly associated with Crooke's hyaline change, while USP48 mutations were more likely to demonstrate cavernous sinus invasion.

ENDOCRINE (2022)

Article Clinical Neurology

Genetic and epigenetic characterization of posterior pituitary tumors

Simone Schmid et al.

Summary: Pituicytoma, granular cell tumor, and spindle cell oncocytoma are rare tumors of the posterior pituitary. Molecular analysis revealed subtle DNA methylation differences but distinct mutation patterns and clinical outcomes, suggesting a combined histo-molecular subclassification into three subtypes based on histology, genetic alterations, and favorable outcomes. The study highlights the potential for targeted therapies based on recurrent genetic alterations in these tumors.

ACTA NEUROPATHOLOGICA (2021)

Letter Clinical Neurology

ICER1 syndrome in a young adult with pituitary blastoma

Anne-Sophie Chong et al.

ACTA NEUROPATHOLOGICA (2021)

Article Endocrinology & Metabolism

Clinical Outcomes and Complications of Pituitary Blastoma

Anthony P. Y. Liu et al.

Summary: Pituitary blastoma is a rare tumor in infancy with a high mortality rate. Surgical resection is the main treatment, with long-term neuroendocrine management being crucial for quality survival. DICER1 abnormalities are commonly associated with this tumor.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Article Endocrinology & Metabolism

USP8 and TP53 Drivers are Associated with CNV in a Corticotroph Adenoma Cohort Enriched for Aggressive Tumors

Andrew Uzilov et al.

Summary: This study found recurrent somatic mutations in USP8 and TP53 genes in corticotroph tumors, which were mutually exclusive and may be independent driver genes. USP8-WT tumors had extensive somatic copy number variation compared with USP8-mutated tumors. The findings suggest that corticotroph tumors can be categorized into a USP8-mutated, genome-stable subtype and a USP8-WT, genome-disrupted subtype with a TP53-mutated subtype.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Article Pathology

Gene of the month: DICER1: ruler and controller

Michelle Thunders et al.

Summary: DICER1 is a crucial RNaseIII endoribonuclease involved in the biogenesis of miRNAs, playing a critical role in post-transcriptional gene silencing. DICER1 deficiency leads to dysregulation of miRNAs, which may contribute to inherited predisposition to cancer and influence tumor development.

JOURNAL OF CLINICAL PATHOLOGY (2021)

Article Clinical Neurology

Molecular characterization of DICER1-mutated pituitary blastoma

Javad Nadaf et al.

Summary: Pituitary blastomas are rare and potentially lethal pediatric intracranial tumors with DICER1 pathogenic variants inducing improper processing of miRNA precursors, leading to dysregulation of miRNAs and mRNA targets. The tumors show dysregulation of key signaling pathways like RAR, WNT, and NOTCH, and activation of PI3K pathway. Comparative methylation profiling reveals distinct features of PitBs compared to other CNS tumors.

ACTA NEUROPATHOLOGICA (2021)

Review Oncology

Management of BRAF-mutant metastatic colorectal cancer: a review of treatment options and evidence-based guidelines

A. Grothey et al.

Summary: Colorectal cancer remains a leading cause of cancer-related deaths globally, with the mutation in the BRAF gene, particularly the V600E substitution, affecting 10% of metastatic CRC patients and indicating a poor prognosis. Recent advancements in combination therapies targeting the MAPK pathway have shown promising results in treating BRAF V600E-mutated mCRC patients, offering new hope in the management of this subtype of cancer.

ANNALS OF ONCOLOGY (2021)

Article Biochemistry & Molecular Biology

The oncogenic role of ubiquitin specific peptidase (USP8) and its signaling pathways targeting for cancer therapeutics

Md. Tariqul Islam et al.

Summary: USP8, as a deubiquitinating enzyme, plays a crucial role in stabilizing oncogenes and proto-oncogenes by activating multiple signaling pathways that promote cancer progression. Inhibiting USP8 could potentially overcome drug resistance in cancer treatment.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2021)

Article Endocrinology & Metabolism

Is there a common cause for paediatric Cushing's disease?

Katarzyna Pasternak-Pietrzak et al.

Summary: This study found that mutations in the USP8 gene may not be as common in pediatric Cushing's disease patients as previously reported, with genetic testing results being negative for the hotspot area of the gene in all samples.

ENDOKRYNOLOGIA POLSKA (2021)

Article Multidisciplinary Sciences

Activating mutations in BRAF disrupt the hypothalamo-pituitary axis leading to hypopituitarism in mice and humans

Angelica Gualtieri et al.

Summary: Mutations in BRAF and other components of the MAP kinase pathway are associated with RASopathies, leading to congenital syndromes such as Septo-Optic Dysplasia and Cardio-Facio-Cutaneous syndrome. The gain-of-function mutations in BRAF are shown to play a critical role in the development of the hypothalamo-pituitary axis, resulting in endocrine deficiencies in patients with RASopathies.

NATURE COMMUNICATIONS (2021)

Article Genetics & Heredity

The landscape and driver potential of site-specific hotspots across cancer genomes

Randi Istrup Juul et al.

Summary: This study utilized large sets of whole cancer genomes to study mutation hotspots, categorize site-specific hotspots, and provide a resource of annotated hotspots genome-wide. The research found an excess of hotspots in protein-coding and gene regulatory regions, as well as identified hotspots associated with cancer genes. Additionally, some hotspots showed clear signs of positive selection.

NPJ GENOMIC MEDICINE (2021)

Article Endocrinology & Metabolism

Associations of GNAS Mutations with Surgical Outcomes in Patients with Growth Hormone-Secreting Pituitary Adenoma

Hyein Jung et al.

Summary: This study found that about 59.5% of Korean patients with acromegaly carried GNAS gene mutations. Patients with GNAS mutations exhibited higher GH expression, higher preoperative insulin-like growth factor-1 levels, and lower postoperative GH levels, as well as higher surgical remission rates.

ENDOCRINOLOGY AND METABOLISM (2021)

Article Oncology

USP8 inhibitor RA-9 reduces ACTH release and cell growth in tumor corticotrophs

Donatella Treppiedi et al.

Summary: RA-9 has shown efficacy in exerting cytotoxic effects and inhibiting cell proliferation and hormone secretion by modulating the expression of pERK1/2, pCREB, and p27. Inhibition of USP8 may represent a novel strategy to target both USP8-WT and USP8-mutated tumors in CD patients.

ENDOCRINE-RELATED CANCER (2021)

Article Biochemistry & Molecular Biology

Somatotroph Tumors and the Epigenetic Status of the GNAS Locus

Pauline Romanet et al.

Summary: This study found that 40% of somatotroph tumors have GNAS mutations, affecting tumor growth and phenotype. Changes in imprinting may impact GNAS expression levels and tumorigenesis, especially in gsp-negative tumors.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Oncology

Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms

David P. Steensma et al.

Summary: H3B-8800 treatment was associated with mostly low-grade treatment-related adverse events and induced red blood cell transfusion independence in a subset of MDS patients.

LEUKEMIA (2021)

Review Genetics & Heredity

Hotspots of Human Mutation

Alex V. Nesta et al.

Summary: This passage discusses the three classes of genomic variation caused by human genome mutations and the potential manifestation of mutations in diseases. It also mentions that with further research on the human genome, more mutation hotspots may be discovered, along with details of their formation and their relevance to evolution and disease.

TRENDS IN GENETICS (2021)

Review Endocrinology & Metabolism

Fibrous Dysplasia/McCune-Albright Syndrome: A Rare, Mosaic Disease of G alpha(s) Activation

Alison M. Boyce et al.

ENDOCRINE REVIEWS (2020)

Article Oncology

Pangenomic Classification of Pituitary Neuroendocrine Tumors

Mario Neou et al.

CANCER CELL (2020)

Article Endocrinology & Metabolism

USP8 Mutations and Cell Cycle Regulation in Corticotroph Adenomas

Clarissa Silva Martins et al.

HORMONE AND METABOLIC RESEARCH (2020)

Review Endocrinology & Metabolism

The Clinical Spectrum of McCune-Albright Syndrome and Its Management

Tiahna Spencer et al.

HORMONE RESEARCH IN PAEDIATRICS (2020)

Review Cell Biology

Argonaute Proteins: From Structure to Function in Development and Pathological Cell Fate Determination

Madlen Muller et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Article Oncology

Activating genomic alterations in the Gs alpha gene (GNAS) in 274 694 tumors

Amit Tirosh et al.

GENES CHROMOSOMES & CANCER (2020)

Article Endocrinology & Metabolism

SST5 expression and USP8 mutation in functioning and silent corticotroph pituitary tumors

Solene Castellnou et al.

ENDOCRINE CONNECTIONS (2020)

Article Multidisciplinary Sciences

Somatic SF3B1 hotspot mutation in prolactinomas

Chuzhong Li et al.

NATURE COMMUNICATIONS (2020)

Article Oncology

Molecular profiling for acromegaly treatment: a validation study

Manel Puig-Domingo et al.

ENDOCRINE-RELATED CANCER (2020)

Review Plant Sciences

Key Mechanistic Principles and Considerations Concerning RNA Interference

Petr Svoboda

FRONTIERS IN PLANT SCIENCE (2020)

Article Neurosciences

Chromosomal instability in the prediction of pituitary neuroendocrine tumors prognosis

Helene Lasolle et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)

Article Endocrinology & Metabolism

Impact of USP8 Gene Mutations on Protein Deregulation in Cushing Disease

Isabel Weigand et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)

Review Cell Biology

Breaking the chains: deubiquitylating enzyme specificity begets function

Michael J. Clague et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)

Editorial Material Oncology

Targeted treatment of papillary craniopharyngiomas harboring BRAF V600E mutations

Tareq A. Juratli et al.

CANCER (2019)

Article Endocrinology & Metabolism

Germline USP8 Mutation Associated With Pediatric Cushing Disease and Other Clinical Features: A New Syndrome

Michal Cohen et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)

Article Oncology

Driver mutations in USP8 wild-type Cushing's disease

Silviu Sbiera et al.

NEURO-ONCOLOGY (2019)

Article Endocrinology & Metabolism

USP8 mutations in corticotroph adenomas determine a distinct gene expression profile irrespective of functional tumour status

Mateusz Bujko et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2019)

Article Endocrinology & Metabolism

The USP8 mutational status may predict long-term remission in patients with Cushing's disease

Adriana Albani et al.

CLINICAL ENDOCRINOLOGY (2018)

Article Clinical Neurology

Do craniopharyngioma molecular signatures correlate with clinical characteristics?

Sacit Bulent Omay et al.

JOURNAL OF NEUROSURGERY (2018)

Article Cell Biology

Cyclic 3 ',5 '-adenosine monophosphate (cAMP) signaling in the anterior pituitary gland in health and disease

Laura C. Hernandez-Ramirez et al.

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)

Article Genetics & Heredity

CHMP1B is a target of USP8/UBPY regulated by ubiquitin during endocytosis

Xenia Crespo-Yanez et al.

PLOS GENETICS (2018)

Article Endocrinology & Metabolism

BRAF V600E mutant papillary craniopharyngiomas: a single-institutional case series

Emanuele La Corte et al.

PITUITARY (2018)

Article Multidisciplinary Sciences

Identification of recurrent USP48 and BRAF mutations in Cushing's disease

Jianhua Chen et al.

NATURE COMMUNICATIONS (2018)

Article Endocrinology & Metabolism

USP8 Mutations in Pituitary Cushing Adenomas-Targeted Analysis by Next-Generation Sequencing

Cora Ballmann et al.

JOURNAL OF THE ENDOCRINE SOCIETY (2018)

Article Endocrinology & Metabolism

Impact of AIP and inhibitory G protein alpha 2 proteins on clinical features of sporadic GH-secreting pituitary adenomas

Elina Ritvonen et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2017)

Article Pathology

Identification of recurrent mutational events in anorectal melanoma

Hui Min Yang et al.

MODERN PATHOLOGY (2017)

Review Cell Biology

Modulating splicing with small molecular inhibitors of the spliceosome

Kerstin A. Effenberger et al.

WILEY INTERDISCIPLINARY REVIEWS-RNA (2017)

Article Endocrinology & Metabolism

Somatic USP8 Gene Mutations Are a Common Cause of Pediatric Cushing Disease

Fabio R. Faucz et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)

Article Pathology

GNAS mutations in primary mucinous and non-mucinous lung adenocarcinomas

Lauren L. Ritterhouse et al.

MODERN PATHOLOGY (2017)

Article Endocrinology & Metabolism

Transcriptome analysis showed a Differential signature between invasive and non-invasive corticotrophinomas

Leonardo Jose Tadeu de Araujo et al.

FRONTIERS IN ENDOCRINOLOGY (2017)

Article Endocrinology & Metabolism

The USP8 mutational status may predict drug susceptibility in corticotroph adenomas of Cushing's disease

Kyohei Hayashi et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)

Article Endocrinology & Metabolism

Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas

Cristina L. Ronchi et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)

Article Genetics & Heredity

High-sensitivity sequencing reveals multi-organ somatic mosaicism causing DICER1 syndrome

Leanne de Kock et al.

JOURNAL OF MEDICAL GENETICS (2016)

Article Chemistry, Medicinal

A druggable target for rescuing microRNA defects

Ken Asada et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)

Review Biochemistry & Molecular Biology

Regulation, Signaling, and Physiological Functions of G-Proteins

Viktoriya Syrovatkina et al.

JOURNAL OF MOLECULAR BIOLOGY (2016)

Article Biochemistry & Molecular Biology

Molecular Architecture of SF3b and Structural Consequences of Its Cancer-Related Mutations

Constantin Cretu et al.

MOLECULAR CELL (2016)

Article Multidisciplinary Sciences

Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage

Samar Alsafadi et al.

NATURE COMMUNICATIONS (2016)

Article Cell Biology

Recurrent gain-of-function USP8 mutations in Cushing's disease

Zeng-Yi Ma et al.

CELL RESEARCH (2015)

Review Endocrinology & Metabolism

Decoding the genetic basis of Cushing's disease: USP8 in the spotlight

Marily Theodoropoulou et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)

Article Pharmacology & Pharmacy

Structural mechanism of G protein activation by G protein-coupled receptor

Nguyen Minh Duc et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2015)

Article Endocrinology & Metabolism

The Gene of the Ubiquitin-Specific Protease 8 Is Frequently Mutated in Adenomas Causing Cushing's Disease

Luis G. Perez-Rivas et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)

Review Multidisciplinary Sciences

Somatic mutation in cancer and normal cells

Inigo Martincorena et al.

SCIENCE (2015)

Article Biochemical Research Methods

Transcriptome Sequencing Reveals Potential Mechanism of Cryptic 3′ Splice Site Selection in SF3B1-mutated Cancers

Christopher DeBoever et al.

PLOS COMPUTATIONAL BIOLOGY (2015)

Article Endocrinology & Metabolism

GNAS Spectrum of Disorders

Serap Turan et al.

CURRENT OSTEOPOROSIS REPORTS (2015)

Article Genetics & Heredity

Mutations in the deubiquitinase gene USP8 cause Cushing's disease

Martin Reincke et al.

NATURE GENETICS (2015)

Article Clinical Neurology

Germ-line and somatic DICER1 mutations in pineoblastoma

Leanne de Kock et al.

ACTA NEUROPATHOLOGICA (2014)

Article Clinical Neurology

Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations

Leanne de Kock et al.

ACTA NEUROPATHOLOGICA (2014)

Article Endocrinology & Metabolism

Exploring the Association Between DICER1 Mutations and Differentiated Thyroid Carcinoma

Leanne de Kock et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)

Review Endocrinology & Metabolism

cAMP in the pituitary: an old messenger for multiple signals

Erika Peverelli et al.

JOURNAL OF MOLECULAR ENDOCRINOLOGY (2014)

Article Genetics & Heredity

Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas

Priscilla K. Brastianos et al.

NATURE GENETICS (2014)

Review Cell Biology

Regulation of microRNA biogenesis

Minju Ha et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)

Article Oncology

Rare SF3B1 R625 mutations in cutaneous melanoma

Yong Kong et al.

MELANOMA RESEARCH (2014)

Article Cell Biology

Rescuing dicer Defects via Inhibition of an Anti-Dicing Nuclease

Ken Asada et al.

CELL REPORTS (2014)

Review Oncology

DICER1: mutations, microRNAs and mechanisms

William D. Foulkes et al.

NATURE REVIEWS CANCER (2014)

Article Oncology

Biallelic DICER1 mutations occur in Wilms tumours

M. K. Wu et al.

JOURNAL OF PATHOLOGY (2013)

Review Biochemistry & Molecular Biology

The role of imprinted genes in humans

Miho Ishida et al.

MOLECULAR ASPECTS OF MEDICINE (2013)

Article Genetics & Heredity

Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma

J. William Harbour et al.

NATURE GENETICS (2013)

Letter Oncology

Germ-Line and Somatic DICER1 Mutations in a Pleuropulmonary Blastoma

Leanne de kock et al.

PEDIATRIC BLOOD & CANCER (2013)

Article Cell Biology

Chromosomal translocations and palindromic AT-rich repeats

Takema Kato et al.

CURRENT OPINION IN GENETICS & DEVELOPMENT (2012)

Article Multidisciplinary Sciences

The landscape of cancer genes and mutational processes in breast cancer

Philip J. Stephens et al.

NATURE (2012)

Article Multidisciplinary Sciences

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

Andrew V. Biankin et al.

NATURE (2012)

Article Medicine, General & Internal

Recurrent Somatic DICER1 Mutations in Nonepithelial Ovarian Cancers

Alireza Heravi-Moussavi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Medicine, General & Internal

RAS Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors

Fei Su et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Medicine, Research & Experimental

EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas

Hidenori Fukuoka et al.

JOURNAL OF CLINICAL INVESTIGATION (2011)

Article Multidisciplinary Sciences

Frequent pathway mutations of splicing machinery in myelodysplasia

Kenichi Yoshida et al.

NATURE (2011)

Review Cell Biology

CREB and the CRTC co-activators: sensors for hormonal and metabolic signals

Judith Y. Altarejos et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)

Article Medicine, General & Internal

Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts

E. Papaemmanuil et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Medicine, General & Internal

SF3B1 and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia

Lili Wang et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Cell Biology

Spliceosome Structure and Function

Cindy L. Will et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2011)

Review Biochemistry & Molecular Biology

Ubiquitin: Same Molecule, Different Degradation Pathways

Michael J. Clague et al.

Article Biochemistry & Molecular Biology

Regulation of Epidermal Growth Factor Receptor Ubiquitination and Trafficking by the USP8.STAM Complex

Ilana Berlin et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Article Multidisciplinary Sciences

RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth

Georgia Hatzivassiliou et al.

NATURE (2010)

Article Multidisciplinary Sciences

DICER1 Mutations in Familial Pleuropulmonary Blastoma

D. Ashley Hill et al.

SCIENCE (2009)

Article Clinical Neurology

Pituitary blastoma

Bernd W. Scheithauer et al.

ACTA NEUROPATHOLOGICA (2008)

Article Multidisciplinary Sciences

Patterns of somatic mutation in human cancer genomes

Christopher Greenman et al.

NATURE (2007)

Article Biochemistry & Molecular Biology

UBPY-mediated epidermal growth factor receptor (EGFR) de-ubiquitination promotes EGFR degradation

Husam A. J. Alwan et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2007)

Article Biochemistry & Molecular Biology

The SF3b155 N-terminal domain is a scaffold important for splicing

Danielle M. Cass et al.

BIOCHEMISTRY (2006)

Article Multidisciplinary Sciences

Structural basis for double-stranded RNA processing by dicer

IJ MacRae et al.

SCIENCE (2006)

Article Multidisciplinary Sciences

TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing

TP Chendrimada et al.

NATURE (2005)

Review Oncology

BRAF mutation in thyroid cancer

M Xing

ENDOCRINE-RELATED CANCER (2005)

Article Cell Biology

GSPα mutations in Mexican patients with acromegaly:: potential impact on long term prognosis

V Mendoza et al.

GROWTH HORMONE & IGF RESEARCH (2005)

Article Oncology

V599EB-RAF is an oncogene in melanocytes

C Wellbrock et al.

CANCER RESEARCH (2004)

Review Oncology

Guilty as charged: B-RAF is a human oncogene

MJ Garnett et al.

CANCER CELL (2004)

Review Cell Biology

The RAF proteins take centre stage

C Wellbrock et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)

Article Endocrinology & Metabolism

Parental origin of Gsα mutations in the McCune-Albright syndrome and in isolated endocrine tumors

G Mantovani et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)

Article Endocrinology & Metabolism

Activating Gsα mutations:: Analysis of 113 patients with signs of McCune-Albright syndrome -: A European Collaborative Study

S Lumbroso et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)

Review Genetics & Heredity

Biased gene conversion: implications for genome and sex evolution

G Marais

TRENDS IN GENETICS (2003)

Article Endocrinology & Metabolism

The Gsα gene:: Predominant maternal origin of transcription in human thyroid gland and gonads

G Mantovani et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)

Review Cell Biology

Seven-transmembrane receptors

KL Pierce et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)

Article Multidisciplinary Sciences

Mutations of the BRAF gene in human cancer

H Davies et al.

NATURE (2002)

Review Endocrinology & Metabolism

Somatic mutations in thyroid nodular disease

K Krohn et al.

MOLECULAR GENETICS AND METABOLISM (2002)

Article Medicine, Research & Experimental

Imprinting of the Gsα gene GNAS1 in the pathogenesis of acromegaly

BE Hayward et al.

JOURNAL OF CLINICAL INVESTIGATION (2001)

Article Multidisciplinary Sciences

Role for a bidentate ribonuclease in the initiation step of RNA interference

E Bernstein et al.

NATURE (2001)

Article Biochemistry & Molecular Biology

An imprinted antisense transcript at the human GNAS1 locus

BE Hayward et al.

HUMAN MOLECULAR GENETICS (2000)